Tumor-infiltrating lymphocytes for advanced gynecological cancers
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a treatment using your own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight advanced or metastatic cervical, ovarian, endometrial, or breast cancer. The cells are taken from a tumor, grown in a lab, and given back to you to help your immune system attack the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced or metastatic cervical, ovarian, endometrial, or breast cancer that has not responded to at least two chemotherapy treatments or cannot be cured with standard treatments.
- You have at least one tumor that can be surgically removed (at least 1.5 cm in size) to obtain immune cells, and at least one other tumor that can be measured (at least 2 cm) to track response.
- You have not had chemotherapy or radiation for at least 28 days before the surgery to remove the tumor.
- Your blood counts and heart, liver, and kidney function are within acceptable limits.
- You do not have active autoimmune diseases, HIV, uncontrolled infections, or brain metastases, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
This early-phase study tests GC201 TIL therapy, made from your tumor’s immune cells (TILs), for advanced or returning gynecologic cancers. If standard treatments have already failed—or there aren’t standard options—this trial may offer a new way to train your immune system to fight the cancer.
This early-phase study tests an experimental cell therapy made from your tumor’s immune cells (TILs) for advanced breast cancer. It may help shrink tumors or improve how long people stay in remission, but it’s still being studied for safety and effectiveness.
This trial tests a treatment where doctors take immune cells from your tumor, grow more of them in the lab, and put them back into your body to fight the cancer. This approach, called TIL therapy, aims to strengthen your own immune system to target ovarian cancer that has come back.
This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer that has progressed after standard therapy. You would have surgery to collect a tumor sample, then receive your expanded immune cells back as an infusion.
Hear when a new Tumor Infiltrating Lymphocytes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.